Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Complement in clinical medicine: Clinical trials, case reports and therapy monitoring
Daniel Ricklin, Andreas Barratt‐Due, Tom Eirik Mollnes
Molecular Immunology (2017) Vol. 89, pp. 10-21
Open Access | Times Cited: 79

Showing 1-25 of 79 citing articles:

Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients
Jan Cato Holter, Søren Erik Pischke, Eline de Boer, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 40, pp. 25018-25025
Open Access | Times Cited: 375
The renaissance of complement therapeutics
Daniel Ricklin, Dimitrios C. Mastellos, Edimara S. Reis, et al.
Nature Reviews Nephrology (2017) Vol. 14, Iss. 1, pp. 26-47
Open Access | Times Cited: 339
Ischemia and Reperfusion Injury in Kidney Transplantation: Relevant Mechanisms in Injury and Repair
Gertrude J. Nieuwenhuijs‐Moeke, Søren Erik Pischke, Stefan P. Berger, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 1, pp. 253-253
Open Access | Times Cited: 230
Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics
Peter Garred, Andrea J. Tenner, Tom Eirik Mollnes
Pharmacological Reviews (2021) Vol. 73, Iss. 2, pp. 792-827
Open Access | Times Cited: 134
Autoimmune hemolytic anemia
Anita Hill, Quentin A. Hill
Hematology (2018) Vol. 2018, Iss. 1, pp. 382-389
Open Access | Times Cited: 135
Microglial inflammation and phagocytosis in Alzheimer's disease: Potential therapeutic targets
Sohaib Nizami, Hazel Hall‐Roberts, Sharat Warrier, et al.
British Journal of Pharmacology (2019) Vol. 176, Iss. 18, pp. 3515-3532
Open Access | Times Cited: 107
Hemolytic Uremic Syndrome
Ellen Cody, Bradley P. Dixon
Pediatric Clinics of North America (2018) Vol. 66, Iss. 1, pp. 235-246
Closed Access | Times Cited: 95
Eculizumab in atypical hemolytic uremic syndrome: strategies toward restrictive use
Kioa L. Wijnsma, Caroline Duineveld, Jack F.M. Wetzels, et al.
Pediatric Nephrology (2018) Vol. 34, Iss. 11, pp. 2261-2277
Open Access | Times Cited: 89
Complement deficiencies and dysregulation: Pathophysiological consequences, modern analysis, and clinical management
Jutta Schröder–Braunstein, Michael Kirschfink
Molecular Immunology (2019) Vol. 114, pp. 299-311
Closed Access | Times Cited: 76
Inflammaging and Complement System: A Link Between Acute Kidney Injury and Chronic Graft Damage
Rossana Franzin, Alessandra Stasi, Marco Fiorentino, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 72
Developments in anti-complement therapy; from disease to clinical trial
Claire L. Harris, Richard B. Pouw, David Kavanagh, et al.
Molecular Immunology (2018) Vol. 102, pp. 89-119
Open Access | Times Cited: 81
Progressive IgA Nephropathy Is Associated With Low Circulating Mannan-Binding Lectin–Associated Serine Protease-3 (MASP-3) and Increased Glomerular Factor H–Related Protein-5 (FHR5) Deposition
Nicholas Medjeral‐Thomas, Anne Troldborg, Nicholas Constantinou, et al.
Kidney International Reports (2017) Vol. 3, Iss. 2, pp. 426-438
Open Access | Times Cited: 77
Be on Target: Strategies of Targeting Alternative and Lectin Pathway Components in Complement-Mediated Diseases
József Dobó, Andrea Kocsis, Péter Gál
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 73
How we treat paroxysmal nocturnal hemoglobinuria: A consensus statement of the Canadian PNH Network and review of the national registry
Christopher J. Patriquin, Thomas Kiss, Stephen Caplan, et al.
European Journal Of Haematology (2018) Vol. 102, Iss. 1, pp. 36-52
Open Access | Times Cited: 61
Complement Activation and Inhibition in Autoimmune Hemolytic Anemia: Focus on Cold Agglutinin Disease
Sigbjørn Berentsen
Seminars in Hematology (2018) Vol. 55, Iss. 3, pp. 141-149
Closed Access | Times Cited: 60
Cytokine Release Syndrome in the Immunotherapy of Hematological Malignancies: The Biology behind and Possible Clinical Consequences
Tor Henrik Anderson Tvedt, Anh Khoi Vo, Øystein Bruserud, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 21, pp. 5190-5190
Open Access | Times Cited: 42
Targeting the complement system in bacterial meningitis
Diederik L H Koelman, Matthijs C. Brouwer, Diederik van de Beek
Brain (2019) Vol. 142, Iss. 11, pp. 3325-3337
Open Access | Times Cited: 48
Clinical and Genetic Spectrum of a Large Cohort With Total and Sub-total Complement Deficiencies
Carine El Sissy, Jérémie Rosain, Paula Vieira‐Martins, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 48
Increased ratios of complement factors C3a to C3 in aqueous humor and serum mark glaucoma progression
Wouter Hubens, Henny J. M. Beckers, T. G. M. F. Gorgels, et al.
Experimental Eye Research (2021) Vol. 204, pp. 108460-108460
Open Access | Times Cited: 35
Complement as a vital nexus of the pathobiological connectome for acute respiratory distress syndrome: An emerging therapeutic target
Zhangsheng Yang, Susannah E. Nicholson, Tomas S. Cancio, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 13
Revisiting the role of the innate immune complement system in ALS
Sandra E. Parker, Angela M. Hanton, Stephen N. Stefanou, et al.
Neurobiology of Disease (2019) Vol. 127, pp. 223-232
Closed Access | Times Cited: 41
Complement System in Cutaneous Squamous Cell Carcinoma
Pilvi Riihilä, Liisa Nissinen, Jaakko Knuutila, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 14, pp. 3550-3550
Open Access | Times Cited: 37
Complement as Prognostic Biomarker and Potential Therapeutic Target in Renal Cell Carcinoma
Britney Reese, Ashok Silwal, Elizabeth A. Daugherity, et al.
The Journal of Immunology (2020) Vol. 205, Iss. 11, pp. 3218-3229
Open Access | Times Cited: 33
Two New Kindreds with Complete Factor D Deficiency
Mathilde Puel, Kenza Rwayane, Paula Vieira Martins, et al.
European Journal of Immunology (2025) Vol. 55, Iss. 3
Open Access
The Extended Use of Eculizumab in Pregnancy and Complement Activation–Associated Diseases Affecting Maternal, Fetal and Neonatal Kidneys—The Future Is Now?
Vedran Stefanović
Journal of Clinical Medicine (2019) Vol. 8, Iss. 3, pp. 407-407
Open Access | Times Cited: 34
Page 1 - Next Page

Scroll to top